Get started
Butterfly Network, Inc.Butterfly Network, Inc.Butterfly Network, Inc.

Butterfly Network, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

BFLY trade ideas

Butterfly Network (BFLY): Handheld Ultrasound Gains TractionButterfly Network, Inc. (BFLY) is revolutionizing medical imaging with its portable, handheld ultrasound technology. Its flagship product, the Butterfly iQ, replaces traditional bulky ultrasound machines with a device that connects to a smartphone or tablet. This innovation makes imaging more accessible and affordable for healthcare providers worldwide. Growth is fueled by increasing adoption in hospitals, clinics, and remote healthcare settings. On the stock chart, BFLY recently showed a confirmation bar with rising volume, moving into the momentum zone. This signals strong investor interest and the potential for continued upside. A trailing stop can be set using Fibonacci levels to help traders manage risk while staying in the trade.
NYSE:BFLYLong
by traderspro_charts
BFLY LONG - Target $6+Been accumulating this stock, Breakout of the downtrend since 2013, Kind of a long post: Butterfly Network has demonstrated impressive growth and operational improvements in its Q3 2024 financial results. With a substantial increase in revenue and a strategic focus on market expansion and cost management, the company appears well-positioned for continued success. 1. Strong Revenue Growth: - Q3 Revenue: $20.6 million, up 33% YoY from $15.4 million. - Annual Revenue Guidance: Increased to $79 million - $81 million, indicating robust growth prospects. 2. Improved Financial Metrics: - Net Loss Reduction: Decreased by 38% to $16.9 million. - Operating Expenses: Reduced by 30% to $29.5 million, showcasing effective cost management. - Gross Profit: Increased to $12.2 million with a solid gross margin of 59.5%. 3. Market Expansion Initiatives: - Launch of the iQ3 device in Europe and entry into new markets such as Indonesia, the Netherlands, and Belgium. - Formation of the new subsidiary, Octiv™, targeting new sectors, indicating diversification of revenue streams. 4. Positive Operational Developments: - Successful adoption of Butterfly technology at the University of Rochester Medical Center and Kansas City University. - New partnerships in veterinary care and upcoming pilot for Butterfly HomeCare’s virtual chronic care management with a Medicare Advantage provider. 5. Strong Market Sentiment: - The fifth consecutive quarter of meeting or exceeding expectations - Insider ownership at 29.52% and an increase in insider transactions signal strong internal belief in the company's future. Given Butterfly Network's robust financial performance, strategic market expansions, and positive operational developments, the stock presents a compelling bullish opportunity. With strong insider ownership and positive analyst sentiment, Im accumulating, First target $6, possible $40 at some point.
NYSE:BFLYLong
by SPYDERMARKET
BFLY Big UP energy for Friday-MonI'm getting that this one as having a possible buyout or something big. The time frame is tomorrow to Monday. I'm wondering if this is going to play out like another one I had, RAVN, earlier in the year. RAVN sold off into a Friday and news of a buyout came at the end of the day on Friday, and then there was a huge gap up and that was that. I'm thinking this could be a similar scenario. Or, it could do like TNDM. I had similar readings on that one, and it had a nice gap up recently. Either way, I want to be very long in this name for the next couple weeks at least in case my timing is off.
NYSE:BFLYLong
by JenRz
BFLY Price Target $20BFLY Current Price $12.20 Price Target $20 I like BFLY here, as it has over $500 million in cash following its merger with Longview, and I like that it is fully expected to be cash-flow positive by 2024.Revenue increased 40.0% to $16.5 million in Q2 2021 from $11.8 million in Q2 2020. The revenue can be traced to both product and subscription revenues. Product revenue increased 30.3% to $13.0 million from $10.0 million last year. That is solid. The company is focused heavily on improving subscriptions, and it is translating to sales. Subscription revenue increased 94.3% to $3.5 million from $1.8 million last year. I see this line of revenue growing sizably in the coming quarters as it becomes a bigger focus of the company. With a half of billion in cash BFLY has significant funds to continue growing their customer base with their innovative cost cutting products. Their Butterfly IQ+ is a handheld ultrasound which is cutting the cost of ultrasounds by over 90%, this opens up the opportunity for the company to expand to developing countries with this amazing cost cutting innovation.
NYSE:BFLYLong
by Value-Invest
BFLY Should Hold SupportBFLY Current Price $12.75 Price Target $20 This company is a fairly valued (5x PE) innovative healthcare company. Butterfly Networks is cutting the cost of ultrasounds by 90% with their handheld device, the new ultrasound platform uses a semiconductor rather than a crystal based sound wave. They are targeting emerging markets with this amazing cost cutting innovation. It hasn’t been a better time to buy BFLY in quite some time as BFLY is now trading on crucial support around $12.50. I think we hold this support line and trade up to the top line of resistance around $15 within the next couple months then we should move up to $20 in the coming months.
NYSE:BFLYLong
by Value-Invest
1
$BFLYButterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
NYSE:BFLYLong
by UnknownUnicorn19246015
BFLY Price Target $25BFLY Current Price $14.36 Price Target $20 $10c 10/15 ($470, 3% till breakeven) We have been in BFLY since $10. This company is a fairly valued (5x PE) innovative healthcare company. Butterfly Networks is cutting the cost of ultrasounds by 90% with their handheld device, the new ultrasound platform uses a semiconductor rather than a crystal based sound wave. They are targeting emerging markets with this amazing cost cutting innovation. We saw insiders buy over 2 million worth of shares earlier this month, which signifies confidence of the business within the company. This is a long term hold for me!
NYSE:BFLYLong
by Value-Invest
Butterfly Network Ready To FLY! This is a stock that is backed by Ark Invest and Bill Gates. It took a hit and has been working it's way back, we see it in a bull flag right now holding above the 50 dma which is a good place to rest before take-off. I would look for a breakout heading out to the 20's...now it is smart to scale out of a trade looking for pulling profits at 20% ROI or so and always manage the risk with a good breakout and a proper 7-8% stop loss. This is for the trade, long term we would look at more fundamentals!
NYSE:BFLYLong
by Vince
BFLY Finding New Support LevelButterfly Network Inc. $BFLY Current Price $13.27 Price Target $20 BFLY $10c 10/15 ($390,4% till breakeven) BFLY has created a handheld ultrasound which can be sold for as low as $2,000 cutting the average price by 90%. This company is young but it is less speculative than most early-stage disruptive companies as BFLY is already selling its product. Given their low barrier to entry and existing product they expect to grow revenue at over 60% for the next four years. This is a long-term hold and you have to believe in the product and the management if you are to invest. However, this pullback may be the best valuation to capture this company's future growth, which is less of an if and more of a when.Butterfly Networks is confirming a new trading range with support at $12.80 which I do expect to hold.
NYSE:BFLYLong
by Value-Invest